N, N-dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an in vitro investigation

Emma Eckernäsa Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
View further author information

Alicia Macan-Schönlebenb Toxicological Centre, University of Antwerp, Wilrijk, BelgiumView further author information

Moa Andresen-Bergströmc Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden;d Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information

Sofia Birgerssona Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, SwedenView further author information

Kurt-Jürgen Hoffmanna Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, SwedenView further author information

Michael Ashtona Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, SwedenView further author information

N, N-dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an in vitro investigation

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

N, N-dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an in vitro investigation

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date